Conversely, individuals with T2DM, obesity, or increased visceral fat tend to have lower IGFBP-2 levels compared to healthy lean subjects [26,27,28,29]. This evidence concerns the gene IGFBP2 and obesity due to melanocortin 4 receptor deficiency.